Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cambrex Corp (CBM)

Cambrex Corp (CBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cambrex Corp ONE MEADOWLANDS PLZ EAST RUTHERFORD NJ 07073 USA

www.cambrex.com P: 201-804-3000

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics.

Key Statistics

Overview:

Market Capitalization, $K 2,023,102
Shares Outstanding, K 33,724
Float, K 33,248
% Float 98.59%
% of Insider Shareholders 1.41%
% of Institutional Shareholders 90.96%

Financials:

Annual Sales, $ 532,090 K
Annual Net Income, $ 92,420 K
Last Quarter Sales, $ 148,560 K
Last Quarter Net Income, $ 9,550 K

Growth:

1-Year Return 21.78%
3-Year Return 14.27%
5-Year Return 153.55%
5-Year Revenue Growth 67.23%
5-Year Earnings Growth 214.77%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.31 on 05/02/19
Next Earnings Date 02/12/20
Earnings Per Share ttm 0.60
EPS Growth vs. Prev Year -68.35%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 14.000 on 05/04/07
Dividend Payable Date 05/03/07
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 06/25/98

CBM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 5.38%
Return-on-Assets % 2.50%
Profit Margin % 17.37%
Debt/Equity 0.76
Price/Sales 3.80
Price/Cash Flow 15.36
Price/Book 2.99
Book Value/Share 20.04
Interest Coverage 28.66
60-Month Beta 2.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar